(Q39007153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Juan Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Gang Zheng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Cheng S Jin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Huang Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Lili Ding

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Zhihong Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

6 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

3072-3082

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24706435%20AND%20SRC:MED&resulttype=core&format=json

Knocking down barriers: advances in siRNA delivery

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

RNAi therapeutics: a potential new class of pharmaceutical drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Rational design of cationic lipids for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

A window onto siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

An influenza virus-inspired polymer system for the timed release of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Nonviral vectors for the delivery of small interfering RNAs to the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

NCI Image-Guided Drug Delivery Summit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Nanotheranostics for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Nanotheranostics and Image-Guided Drug Delivery: Current Concepts and Future Directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

In vivo imaging of siRNA delivery and silencing in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Are quantum dots ready for in vivo imaging in human subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emissi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

In vivo imaging of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Inhibition of lung carcinoma cell growth by high density lipoprotein-associated alpha-tocopheryl-succinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

QUANTIFYING NANOPARTICLE TRANSPORT IN VIVO USING HYPERSPECTRAL IMAGING WITH A DORSAL SKINFOLD WINDOW CHAMBER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

Reconstituted low density lipoprotein: A vehicle for the delivery of hydrophobic fluorescent probes to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842

HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201303842